Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721808 · ClinicalTrials.gov registry record
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1,712
- Enrollment target
NCT04721808 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1,712 participants.
The verdict
NCT04721808 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1,712 participants
- Enrollment target
Study Summary
This study is to investigate and describe the treatment patterns and effect of tofacitinib indicators for patients with Rheumatoid Arthritis (RA) assessing real world patient data entered in the Corrona RA Registry on or after November 2012
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,712 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2021-11-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721808
The ClinicalTrials.gov registry entry for NCT04721808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,712 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04721808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04721808 about?
NCT04721808 is a clinical study titled "A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis". This study is to investigate and describe the treatment patterns and effect of tofacitinib indicators for patients with Rheumatoid Arthritis (RA) assessing real world patient data entered in the Corrona RA Registry on or after November 2012
What is the current status of trial NCT04721808?
This trial is currently completed. The enrollment target is 1,712 participants. The study started on 2021-01-22. Estimated completion is 2021-11-24.
Who is sponsoring clinical trial NCT04721808?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.